Cogent Biosciences, Inc. (COGT) NASDAQ
32.93
+1.675(+5.36%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
32.93
+1.675(+5.36%)
Currency In USD
| Market Cap | 2.4B |
| Enterprise Value | 2.34B |
| P/E Ratio | -6.26 |
| PEG Ratio | 0.23 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.65 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -15.53 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.39 |
| Return On Equity | -0.83 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -4.62M |
| EBITDA | -328.74M |
| Net Income | -328.94M |
| Diluted EPS | -2.55 |
| Total Cash | 866.38M |
| Total Cash/Share | 12.85 |
| Total Debt | 238.65M |
| Total Debt/Equity | 0.39 |
| Current Ratio | 15.14 |
| Book Value Per Share | 9.01 |
| 52-Week Change | 520.06 |
| 52-Week High | 43.73 |
| 52-Week Low | 4.75 |
| Moving Average 50 Days | 35.6 |
| Moving Average 200 Days | 28.84 |
| Average Volume | 2.02M |
| Shares Outstanding | 170.87M |
| % Held by Institutions | 91.83 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | November 09, 2020 |